Cargando…

Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?

Detalles Bibliográficos
Autores principales:	Luzum, Jasmine A., Lanfear, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943290/ https://www.ncbi.nlm.nih.gov/pubmed/27021567 http://dx.doi.org/10.1161/JAHA.116.003440

Ejemplares similares

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
por: Oemrawsingh, Rohit M., et al.
Publicado: (2016)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

BNP and Precision Medicine: Tip of an Iceberg
por: Lanfear, David E., et al.
Publicado: (2021)

Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources
por: Shugg, Tyler, et al.
Publicado: (2020)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

Effectiveness and Tolerability of the Single-Pill Combination of Bisoprolol and Perindopril in Patients with Arterial Hypertension and Stable Coronary Artery Disease in Daily Clinical Practice: The STYLE Study
por: Boytsov, Sergey A., et al.
Publicado: (2021)

Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study
por: Dézsi, Csaba András
Publicado: (2018)

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study
por: Brugts, J. J., et al.
Publicado: (2011)

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
por: Verbelen, M, et al.
Publicado: (2017)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study
por: Perlis, Roy H., et al.
Publicado: (2009)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

When a COVID-19 vaccine is ready, will we all be ready for it?
por: Fadda, Marta, et al.
Publicado: (2020)

Percutaneous Coronary Intervention in Anomalous Right Coronary Artery: Ready to Implement in Clinical Routine?
por: Stark, Anselm W, et al.
Publicado: (2022)

Perindopril/amlodipine-induced thrombotic microangiopathy
por: Periša, Vlatka, et al.
Publicado: (2020)

Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review
por: Morris, Sarah A., et al.
Publicado: (2022)

CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort
por: Kitzmiller, Joseph P., et al.
Publicado: (2014)

A Review of Perindopril in the Reduction of Cardiovascular Events
por: Campbell, Duncan J
Publicado: (2006)

Perindopril: the evidence of its therapeutic impact in hypertension
por: Thomson, Andrew, et al.
Publicado: (2007)

Evaluation of analgesic activity of perindopril in albino mice
por: Suresha, R. N., et al.
Publicado: (2014)

Efficacy and Safety of Perindopril in Patients with Essential Hypertension
por: Hodzic, Enisa, et al.
Publicado: (2020)

Cancer diagnostics and treatment: are we ready to implement PPPM?
por: Desiderio, Dominic M.
Publicado: (2010)

Are We Ready to Implement Circadian Hygiene Interventions and Programs?
por: Moreno, Claudia R. C., et al.
Publicado: (2022)

Pharmacogenetic Variants in the DPYD and TYMS Genes are Clinically Significant Predictors of Fluoropyrimidine Toxicity: Are We Ready for Use in our Clinical Practice
por: Saif, Muhammad Wasif, et al.
Publicado: (2020)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Exercise Capacity, Coronary Artery Fatty Plaque, Coronary Calcium Score, and Cardiovascular Events in Subjects With Stable Coronary Artery Disease
por: Malik, Abdulaziz, et al.
Publicado: (2020)

Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014)

Are we ready?()
por: Pedrosa, C.
Publicado: (2020)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

Perindopril-induced angioedema of the lips and tongue: a case report
por: Alharbi, Fawaz Abdullah, et al.
Publicado: (2018)

A rare cause of pediatric acute pancreatitis: Perindopril intoxication
por: Misirlioglu, Merve, et al.
Publicado: (2020)

Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use
por: Syed, Yahiya Y.
Publicado: (2022)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

Are We Ready to Implement Competence-Based Teaching in Pharmacy Education in Poland?
por: Skowron, Agnieszka, et al.
Publicado: (2017)

We are ready for clinical implementation of Carbon Ion Radiotherapy in the United States
por: Beltran, Chris, et al.
Publicado: (2020)

The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease
por: Özyılmaz, Sinem, et al.
Publicado: (2016)

Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease
por: Ishii, Masanobu, et al.
Publicado: (2023)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Identification of Aortic Proteins Involved in Arterial Stiffness in Spontaneously Hypertensive Rats Treated With Perindopril:A Proteomic Approach
por: Miotto, Danyelle S., et al.
Publicado: (2021)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t4t5hva6biq6pv36oljihvb4r8